News and Announcements
SUDA Update on HC Berlin Pharma
- Published June 06, 2016 4:52PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd June 2016, ASX Announcement
SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it has received a Statement of Claim in relation to a lawsuit between the Company and HC Berlin Pharma AG (in liquidation).
A review by our legal advisors in Germany has identified that the Statement of Claim contains assertions that are not based on fact, therefore based on our legal advice, the Directors of SUDA believe that the claim is without significant merit and will be vigorously defended.
In 2008, HC Berlin Pharma entered into an agreement with SUDA (then Eastland Medical Systems Ltd) for certain manufacturing rights. The licence granted to HC Berlin Pharma was subject of an in-kind capital contribution and SUDA was issued with shares in the capital of HC Berlin Pharma in exchange for these rights.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
